RP
Schedule 13G filing
Regal Partners Funds Management Pty Ltd cut its Radiopharm Theranostics Ltd (RADX) stake below 5%
Regal Partners Funds Management Pty Ltd reported owning 3.3% of Radiopharm Theranostics Ltd (RADX) (157,139,443 shares) in a Schedule 13G filed Oct 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 15, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.